ArticleNature communications2025

CAR macrophages with built-In CD47 blocker combat tumor antigen heterogeneity and activate T cells via cross-presentation.

Siqi Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.